Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Tanya Kovalova
Institutions:
Population Health Research Institute,
Hamilton Health Sciences,
McMaster University
Observed institutions:
Population Health Research Institute,
Hamilton Health Sciences,
McMaster University
ORCID:
0009-0008-9885-6507
Observed ORCID:
0009-0008-9885-6507
OpenAlex ID:
A5038780234
Small-Volume Blood Collection Tubes to Reduce Transfusions in Intensive Care: The STRATUS Randomized Clinical Trial
2023
·
Deborah M. Siegal
, Emilie P. Belley-Côté
, et al.
·
JAMA
·
57
PDF
Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin
2023
·
Isabelle Johansson
, Alexander P. Benz
, et al.
·
Thrombosis and Haemostasis
·
22
PDF
Intracoronary Low-Dose Recombinant Tissue Plasminogen Activator in Primary PCI for ST-Segment Elevation Myocardial Infarction and Large Thrombus Burden
2025
·
Shamir R. Mehta
, Natalia Pinilla-Echeverri
, et al.
·
Journal of the American College of Cardiology
·
14
Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation
2024
·
Vinai Bhagirath
, Tanya Kovalova
, et al.
·
TH Open
·
6
PDF
Do Children With an Allergic Transfusion Reaction Require Premedication For All Blood Products?
2023
·
Aban Bahabri
, Rebecca Barty
, et al.
·
Journal of Pediatric Hematology/Oncology
·
3
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiA
2026
·
Maria Hee Jung Park Frausing
, William F McIntyre
, et al.
·
European Journal of Heart Failure
·
1
Corrigendum: Bleeding Risk Prediction in Patients Treated with Antithrombotic Drugs According to the Anatomic Site of Bleeding, Indication for Treatment, and Time Since Treatment Initiation
2024
·
Vinai Bhagirath
, Tanya Kovalova
, et al.
·
TH Open
·
1
PDF
Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE ‐O Trial
2026
·
Daniel Raaschou‐Oddershede
, Christine R. Schwarz
, et al.
·
Diabetes Obesity and Metabolism
Author response for "Potential Mediators of Efpeglenatide’s Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O trial"
2026
·
Daniel Raaschou‐Oddershede
, Christine R. Schwarz
, et al.
·
Publons reviews and discussion
Author response for "Potential Mediators of Efpeglenatide’s Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O trial"
2026
·
Daniel Raaschou‐Oddershede
, Christine R. Schwarz
, et al.
·
Publons reviews and discussion
Show more works
View as search
Works count:
10
Citation count:
104
H-index:
4
I10-index:
3
Year
Topic
Type